Factors Associated with Knowledge and Attitude towards E-Cigarettes among Undergraduate Students in Thailand: A Cross-Sectional Study.

BACKGROUND: Thailand government has enacted a ban on vaping for eight years, but the number of vapers has continued to increase, particularly among teenagers. This study aimed to evaluate undergraduate pharmacy students' knowledge and attitudes toward e-cigarette use in Thailand. METHOD: This descriptive cross-sectional study was performed between January and March 2022. The participants were selected from 14 universities of Thailand. For data collection, a questionnaire was developed online using Google Form. The participants had to complete the questionnaire within 5 to 10 days the via s. Chi-square and binary logistic analysis were used to assess the association between variables. RESULTS: A total of 507 participants were recruited, The participants' mean age was 20.6 ± 1.9 years. About 98.6% of the participants knew about e-cigarette, and 74.4% had never been taught about e-cigarettes. Moreover, 68.8% of the participants declared that people around them were smokers. Logistic regression analysis indicated that the participants who declared that they were not sure if e-cigarettes contains nicotine or not were 10.5 more likely to consume e-cigarettes (AOR = 10.5; 95 % CI 3.130-35.181; P ˂0.001). Male participants who were at the academic year of three and four were more likely to use e-cigarettes than female students who were at the academic year of five and six (AOR 2.9; 95 % CI 1.599-5.214; P ˂0.001; AOR = 4.5; 95 % CI 1.412-14.571; P ˂0.001; AOR = 3.9; 95 % CI 1.263-12.511; p = 0.018). CONCLUSION: OOur study findings showed that pharmacy students lacked knowledge about e-cigarettes and misunderstood about e-cigarettes substances. Future research is necessary to develop educational programs for health professionals to be ready to advise patients about e-cigarettes.

Levofloxacin Use in Patients with Suspected Tuberculosis in a Community Hospital, Thailand: A Pilot Study.

Background: Levofloxacin is one of the broad-spectrum antibiotics that is indicated for the second-line treatment of tuberculosis (TB). However, using levofloxacin as an empirical therapy for patients without confirmation of TB could still be observed. This descriptive retrospective study, therefore, aimed to investigate the number of levofloxacin use in patients suspected TB in a community hospital in Thailand. Methods: Patient medical charts of all patients who were admitted to a community hospital in Nakhon Si Thammarat, Thailand, from 2016 to 2017, were reviewed. Patients who were suspected TB and received any levofloxacin-containing regimens were included. Data on patient characteristics and the received regimens were descriptively analyzed and reported as percentage and frequency. Results: There were a total of 21 patients who received levofloxacin in the hospital. Six of them (28.57%) had the diagnosis of hepatitis. The most prescribed regimen as empirical therapy was levofloxacin, ethambutol, and amikacin (66.67%). After the confirmation of TB using acid-fast bacilli (AFB) test, ten patients (47.62%) still received levofloxacin-containing regimens. Conclusion: The results from this study indicated high usage of levofloxacin despite no evidence of drug-resistant TB or negative AFB results in a community hospital in Thailand. The results from this study will be further used for the investigation of the prevalence of antibiotic resistance and clinical outcomes of using second-line regimens for TB treatment.